Posttranslational Modifications in Pathogenesis of PCOS

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Oct 24

PMID 36277727

Authors

Huimei Wei

Peng Huo

Shun Liu

Hua Huang

Shun Zhang

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a lifelong reproductive, metabolic, and psychiatric disorder that affects 5-18% of women, which is associated with a significantly increased lifetime risk of concomitant diseases, including type 2 diabetes, psychiatric disorders, and gynecological cancers. Posttranslational modifications (PTMs) play an important role in changes in protein function and are necessary to maintain cellular viability and biological processes, thus their maladjustment can lead to disease. Growing evidence suggests the association between PCOS and posttranslational modifications. This article mainly reviews the research status of phosphorylation, methylation, acetylation, and ubiquitination, as well as their roles and molecular mechanisms in the development of PCOS. In addition, we briefly summarize research and clinical trials of PCOS therapy to advance our understanding of agents that can be used to target phosphorylated, methylated, acetylated, and ubiquitinated PTM types. It provides not only ideas for future research on the mechanism of PCOS but also ideas for PCOS treatments with therapeutic potential.

Citing Articles

Role of protein post-translational modifications in unexplained recurrent pregnancy loss.

Gao Q, Ren J, Niu D, Guo L, Feng X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(9):1495-1502.

PMID: 39931779 PMC: 11814392. DOI: 10.11817/j.issn.1672-7347.2024.240365.

Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study.

Yurtkal A, Canday M Diagnostics (Basel). 2024; 14(14).

PMID: 39061689 PMC: 11276556. DOI: 10.3390/diagnostics14141553.

Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics.

Liu S, Zhao X, Meng Q, Li B PLoS One. 2023; 18(10):e0293447.

PMID: 37883387 PMC: 10602247. DOI: 10.1371/journal.pone.0293447.

Therapeutic Effects and Molecular Mechanism of Chlorogenic Acid on Polycystic Ovarian Syndrome: Role of HIF-1alpha.

Zhang Z, Shi C, Wang Z Nutrients. 2023; 15(13).

PMID: 37447160 PMC: 10343257. DOI: 10.3390/nu15132833.

Effects of Decamethylcyclopentasiloxane on Reproductive Systems in Female Rats.

Lee J, Kim K, Park S, Kwon J, Jeung E Toxics. 2023; 11(4).

PMID: 37112528 PMC: 10143965. DOI: 10.3390/toxics11040302.

References

Sacco F, Seelig A, Humphrey S, Krahmer N, Volta F, Reggio A . Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets. Cell Metab. 2019; 29(6):1422-1432.e3. DOI: 10.1016/j.cmet.2019.02.012. View

Jin J, Ma Y, Tong X, Yang W, Dai Y, Pan Y . Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod. 2020; 35(5):1145-1158. PMC: 7259369. DOI: 10.1093/humrep/deaa077. View

Wang J, Wu D, Guo H, Li M . Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci. 2019; 236:116940. DOI: 10.1016/j.lfs.2019.116940. View

Sun Z, Zhang H, Wang X, Wang Q, Zhang C, Wang J . TMCO1 is essential for ovarian follicle development by regulating ER Ca store of granulosa cells. Cell Death Differ. 2018; 25(9):1686-1701. PMC: 6143536. DOI: 10.1038/s41418-018-0067-x. View

Wang M, Lin H . Understanding the Function of Mammalian Sirtuins and Protein Lysine Acylation. Annu Rev Biochem. 2021; 90:245-285. DOI: 10.1146/annurev-biochem-082520-125411. View

Nolan T, Brennan B, Yang M, Chen J, Zhang M, Li Z . Selective Autophagy of BES1 Mediated by DSK2 Balances Plant Growth and Survival. Dev Cell. 2017; 41(1):33-46.e7. PMC: 5720862. DOI: 10.1016/j.devcel.2017.03.013. View

Masjedi F, Keshtgar S, Zal F, Talaei-Khozani T, Sameti S, Fallahi S . Effects of vitamin D on steroidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries. J Steroid Biochem Mol Biol. 2019; 197:105521. DOI: 10.1016/j.jsbmb.2019.105521. View

Luo Z, Wang W, Li F, Songyang Z, Feng X, Xin C . Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes. Mol Cancer. 2019; 18(1):106. PMC: 6556968. DOI: 10.1186/s12943-019-1035-x. View

Ma X, Li X, Ma L, Chen Y, He S . Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway. Bioengineered. 2021; 12(1):7215-7223. PMC: 8806892. DOI: 10.1080/21655979.2021.1979864. View

10.

Coffey K, Robson C . Regulation of the androgen receptor by post-translational modifications. J Endocrinol. 2012; 215(2):221-37. DOI: 10.1530/JOE-12-0238. View

11.

Wang D, Wang T, Wang R, Zhang X, Wang L, Xiang Z . Suppression of p66Shc prevents hyperandrogenism-induced ovarian oxidative stress and fibrosis. J Transl Med. 2020; 18(1):84. PMC: 7027222. DOI: 10.1186/s12967-020-02249-4. View

12.

Zhi T, Jiang K, Xu X, Yu T, Zhou F, Wang Y . ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1. Neuro Oncol. 2018; 21(4):462-473. PMC: 6422441. DOI: 10.1093/neuonc/noy207. View

13.

Eini F, Novin M, Joharchi K, Hosseini A, Nazarian H, Piryaei A . Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome. Reprod Fertil Dev. 2017; 29(12):2313-2323. DOI: 10.1071/RD16428. View

14.

Iervolino M, Lepore E, Forte G, Lagana A, Buzzaccarini G, Unfer V . Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review. Nutrients. 2021; 13(5). PMC: 8156462. DOI: 10.3390/nu13051677. View

15.

Chen M, He C, Zhu K, Chen Z, Meng Z, Jiang X . Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication. Theranostics. 2022; 12(2):782-795. PMC: 8692920. DOI: 10.7150/thno.67167. View

16.

Cozzolino M, Herraiz S, Titus S, Roberts L, Romeu M, Peinado I . Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response. Hum Reprod. 2022; 37(6):1274-1286. PMC: 9156844. DOI: 10.1093/humrep/deac069. View

17.

Leutert M, Entwisle S, Villen J . Decoding Post-Translational Modification Crosstalk With Proteomics. Mol Cell Proteomics. 2021; 20:100129. PMC: 8430371. DOI: 10.1016/j.mcpro.2021.100129. View

18.

Kakuta H, Iguchi T, Sato T . The Involvement of Granulosa Cells in the Regulation by Gonadotropins of in Theca Cells. In Vivo. 2018; 32(6):1387-1401. PMC: 6365763. DOI: 10.21873/invivo.11391. View

19.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

20.

Guo X, Puttabyatappa M, Thompson R, Padmanabhan V . Developmental Programming: Contribution of Epigenetic Enzymes to Antral Follicular Defects in the Sheep Model of PCOS. Endocrinology. 2019; 160(10):2471-2484. PMC: 6760338. DOI: 10.1210/en.2019-00389. View